Keeley-Teton Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $218K | Hold |
3,570
| – | – | 0.03% | 353 |
|
|
2024
Q4 | $202K | Sell |
3,570
-1,500
| -30% | -$84.8K | 0.02% | 363 |
|
|
2024
Q3 | $262K | Buy |
+5,070
| New | +$262K | 0.03% | 359 |
|
|
2024
Q1 | – | Sell |
-3,927
| Closed | -$201K | – | 349 |
|
|
2023
Q4 | $201K | Hold |
3,927
| – | – | 0.03% | 342 |
|
|
2023
Q3 | $228K | Sell |
3,927
-600
| -13% | -$34.8K | 0.03% | 330 |
|
|
2023
Q2 | $290K | Hold |
4,527
| – | – | 0.04% | 320 |
|
|
2023
Q1 | $314K | Buy |
4,527
+600
| +15% | +$41.6K | 0.04% | 332 |
|
|
2022
Q4 | $283K | Sell |
3,927
-491
| -11% | -$35.3K | 0.04% | 341 |
|
|
2022
Q3 | $314K | Buy |
4,418
+491
| +13% | +$34.9K | 0.04% | 321 |
|
|
2022
Q2 | $302K | Sell |
3,927
-305
| -7% | -$23.5K | 0.04% | 336 |
|
|
2022
Q1 | $309K | Hold |
4,232
| – | – | 0.03% | 348 |
|
|
2021
Q4 | $264K | Buy |
+4,232
| New | +$264K | 0.03% | 301 |
|
|
2021
Q2 | – | Sell |
-4,232
| Closed | -$267K | – | 276 |
|
|
2021
Q1 | $267K | Hold |
4,232
| – | – | 0.03% | 295 |
|
|
2020
Q4 | $263K | Buy |
4,232
+2
| +0% | +$124 | 0.04% | 238 |
|
|
2020
Q3 | $255K | Buy |
4,230
+3
| +0.1% | +$181 | 0.04% | 226 |
|
|
2020
Q2 | $249K | Buy |
4,227
+2
| +0% | +$118 | 0.04% | 224 |
|
|
2020
Q1 | $236K | Buy |
4,225
+2
| +0% | +$112 | 0.04% | 227 |
|
|
2019
Q4 | $271K | Buy |
4,223
+2
| +0% | +$128 | 0.03% | 240 |
|
|
2019
Q3 | $214K | Buy |
+4,221
| New | +$214K | 0.02% | 254 |
|